VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

Cardinal Health Executive Compensation (FY26)

CAH · Executive and director compensation, fiscal 2022 to 2026
Chief executive, fiscal 2026
◇
Jason Hollar
Latest say-on-pay support
=
November 5, 2025
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The Cardinal Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Cardinal Health brief$500Get the executive brief
Velarion Intel, one year, every company
293 figures on this page: 283 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2025 to fiscal 2026
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Jason Hollar: $18,976,195 → $22,574,349 (19.0% higher)
Say-on-pay support: 89.6% → 90.7% (1.1 points higher)
CEO pay ratio: 261:1 → 288:1 (10.3% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Cardinal Health's chief executive and what were they paid?
Jason Hollar, Chief Executive Officer, received $22,574,349 in total compensation for fiscal 2026. Compared with the $18,976,195 reported for fiscal 2025, Hollar's total was 19.0% higher.
What was Cardinal Health's say-on-pay result?
The say-on-pay proposal drew 90.7% of votes cast for or against in favor at the meeting held November 5, 2025 for fiscal 2025.
Which companies are in Cardinal Health's peer group?
The disclosed peer group includes Accendra Health, Inc., Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation and Cencora, Inc., among others.
What is Cardinal Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2026 is 288:1, against median employee compensation of $78,316.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Kaufmann
Former Chief Executive Officer
◇—◇—◇—◇◇
Jessica Mayer
Chief Legal and Compliance Officer
◇—◇—◇—◇◇
Jason Hollar
Chief Executive Officer
◇—◇—◇—◇◇
Victor Crawford
Former Chief Executive Officer, Pharmaceutical Segment
◇—◇—◇—◇◇
Stephen Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Hollar
Chief Executive Officer
◇—◇—◇—◇◇
Aaron Alt
Chief Financial Officer
◇◇◇◇◇—◇◇
Victor Crawford
Former Chief Executive Officer, Pharmaceutical Segment
Departed during or after this year
◇—◇———◇◇
Stephen Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
◇—◇—◇—◇◇
Jessica Mayer
Chief Legal and Compliance Officer
◇—◇—◇—◇◇
Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
◇—◇—◇—◇◇
Michael Kaufmann
Former Chief Executive Officer
Departed during or after this year
◇—————◇◇
Patricia English
Former Interim Chief Financial Officer
Departed during or after this year
Served on an interim basis
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Hollar
Chief Executive Officer
◇—◇—◇—◇◇
Stephen Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
◇—◇—◇—◇◇
Aaron Alt
Chief Financial Officer
◇—◇—◇—◇◇
Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
◇—◇—◇—◇◇
Jessica Mayer
Chief Legal and Compliance Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Hollar
Chief Executive Officer
◇—◇—◇—◇◇
Aaron Alt
Chief Financial Officer
◇—◇—◇—◇◇
Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
◇—◇—◇—◇◇
Jessica Mayer
Chief Legal and Compliance Officer
◇—◇—◇—◇◇
Stephen Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
◇—◇—◇—◇◇
Fiscal 2026
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Hollar
Chief Executive Officer
◇—◇—◇—◇◇
Aaron Alt
Chief Financial Officer
◇—◇—◇—◇◇
Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
◇—◇—◇—◇◇
Jessica Mayer
Chief Legal and Compliance Officer
◇—◇—◇—◇◇
Stephen Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Aaron AltPSU◇◇◇—◇—◇
Aaron AltRSU◇——◇——◇
Deborah WeitzmanPSU◇◇◇—◇—◇
Deborah WeitzmanRSU◇——◇——◇
Jason HollarPSU◇◇◇—◇—◇
Jason HollarRSU◇——◇——◇
Jessica MayerPSU◇◇◇—◇—◇
Jessica MayerRSU◇——◇——◇
Stephen MasonPSU◇◇◇—◇—◇
Stephen MasonRSU◇——◇——◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2026 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Jason HollarPSU◇◇——
RSU◇◇——
Aaron AltPSU◇◇——
RSU◇◇——
Deborah WeitzmanPSU◇◇——
RSU◇◇——
Stephen MasonPSU◇◇——
RSU◇◇——
Jessica MayerPSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2026
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Gregory B. Kenny
◇◇———◇◇
Patricia A. Hemingway Hall
Board chair
◇◇———◇◇
Sheri H. Edison
◇◇———◇◇
Nancy Killefer
◇◇———◇◇
David C. Evans
◇◇———◇◇
Akhil Johri
◇◇———◇◇
Robert W. Musslewhite
◇◇———◇◇
Robert W. Azelby
◇◇———◇◇
Sudhakar Ramakrishna
◇◇———◇◇
Michelle M. Brennan
◇◇————◇
Christine A. Mundkur
◇◇————◇
Jason M. Hollar served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2026
  • Accendra Health, Inc. ACH
  • Baxter International Inc. BAX
  • Becton, Dickinson and Company BDX
  • Boston Scientific Corporation BSX
  • Cencora, Inc. COR
  • CVS Health Corporation CVS
  • Danaher Corporation DHR
  • Elevance Health, Inc. ELV
  • FedEx Corporation FDX
  • Henry Schein, Inc. HSIC
  • Johnson & Johnson JNJ
  • Labcorp Holdings Inc. LH
  • McKesson Corporation MCK
  • Stryker Corporation SYK
  • Sysco Corporation SYY
  • Target Corporation TGT
  • The Cigna Group CI
  • The Kroger Co. KR
  • Thermo Fisher Scientific Inc. TMO
  • United Parcel Service, Inc. UPS
  • UnitedHealth Group Incorporated UNH
  • Walgreens Boots Alliance, Inc. WBA

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025November 5, 2025=◇◇◇
2024November 6, 2024=◇◇◇
2023November 15, 2023=◇◇◇
2022November 9, 2022=◇◇◇
2021November 5, 2021=◇◇◇
2020November 4, 2020=◇◇◇
2019November 6, 2019=◇◇◇
2018November 7, 2018=◇◇◇
2017November 8, 2017=◇◇◇
2016November 3, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Jason Hollar (Chief Executive Officer), FY2026 total compensation $22,574,349 (base salary $1,500,000) [exec_comp, SEC accession 0001308179-26-000402, filed 2026-09-21]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Cardinal Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Cardinal Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Cardinal Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Cardinal Health's disclosed peer group is defensible, who names Cardinal Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
293 figures on this page: 283 cited to the filing that reported them, 10 calculated from figures it prints.
283 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001308179-26-000402
    Director Compensation · Executive Compensation Tables · Pay Ratio Disclosure
  2. 0000721371-25-000133
    Item 5.07 Submission of Matters to a Vote of Security Holders
  3. 0000721371-25-000114
    Grants of Plan-Based Awards
  4. 0000721371-24-000132
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0000721371-24-000103
    Executive Compensation Tables
  6. 0000721371-23-000094
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001308179-23-001007
    Summary Compensation Table
  8. 0000721371-22-000144
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000721371-21-000120
  10. 0000721371-20-000133
  11. 0000721371-19-000129
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0000721371-18-000104
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0000721371-17-000169
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0000721371-16-000353
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Cardinal Health executive compensation, FY2022–FY2026.” https://intel.velarion.ai/comp/CAH (accessed 2026).
Short form: data: Velarion

The Cardinal Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Cardinal Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Peers Cardinal Health discloses

The companies named in CAH's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}